有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 3-[(1R)-cyclohex-2-en-1-yl]sulfanyl-5-(oxan-4-yl)-1,2,4-triazol-4-amine | —— | C13H20N4OS |
|
—— | 2-(4-chlorophenyl)sulfanyl-N'-[1-(2,4-dimethylpyrrol-3-ylidene)ethyl]acetohydrazide | —— | C16H18ClN3OS |
|
—— | N-[[4-(dimethylamino)phenyl]methyl]-2-(1-methyltetrazol-5-yl)sulfanylacetamide | —— | C13H18N6OS |
|
—— | 1-Methyl-5-[[3-[(1-methyltetrazol-5-yl)sulfanylmethyl]phenyl]methylsulfanyl]tetrazole | —— | C12H14N8S2 |
|
—— | ethyl 5-[[2-[2-(4-chlorophenyl)sulfanylacetyl]hydrazinyl]methylidene]-2,4-dimethylpyrrole-3-carboxylate | —— | C18H20ClN3O3S |
|
—— | 5-(Furan-2-yl)-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-1,2-oxazole | —— | C10H9N5O2S |
|
—— | 2-(1-methyltetrazol-5-yl)sulfanyl-1-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)ethanone | —— | C15H17N5OS |
|
—— | N-[(2-fluorophenyl)methyl]-2-(1-methyltetrazol-5-yl)sulfanylacetamide | —— | C11H12FN5OS |
|
—— | 2-(4-chlorophenyl)sulfanyl-N-[(Z)-[2,5-dimethyl-1-(1,3-thiazol-2-yl)pyrrol-3-yl]methylideneamino]acetamide | —— | C18H17ClN4OS2 |
|
—— | (2S)-2-methylsulfonyl-N-(2-phenylsulfanylphenyl)propanamide | —— | C16H17NO3S2 |
|
—— | (2R)-N-[5-chloro-2-(2,4-dimethylphenyl)sulfanylphenyl]-2-methylsulfonylpropanamide | —— | C18H20ClNO3S2 |
|
—— | N-[(Z)-[(E)-3-(1-benzyltriazol-4-yl)prop-2-enylidene]amino]-2-(4-chlorophenyl)sulfanylacetamide | —— | C20H18ClN5OS |
|
—— | (2R)-N-(2-methylpropyl)-2-[1-(pyridin-2-ylmethyl)imidazol-2-yl]sulfanylpropanamide | —— | C16H22N4OS |
|
—— | 3-[(1S)-cyclohex-2-en-1-yl]sulfanyl-5-(oxan-4-yl)-1,2,4-triazol-4-amine | —— | C13H20N4OS |
|
—— | 3-[(1R)-1-(3-methylphenyl)ethyl]sulfanyl-5-(oxan-4-yl)-1,2,4-triazol-4-amine | —— | C16H22N4OS |
|
—— | (2S)-N-[5-chloro-2-(2,4-dimethylphenyl)sulfanylphenyl]-2-methylsulfonylpropanamide | —— | C18H20ClNO3S2 |
|
—— | 2-(1-methyltetrazol-5-yl)sulfanyl-N-[(R)-phenyl(thiophen-2-yl)methyl]acetamide | —— | C15H15N5OS2 |
|
—— | 3-[(1S)-1-(3-methylphenyl)ethyl]sulfanyl-5-(oxan-4-yl)-1,2,4-triazol-4-amine | —— | C16H22N4OS |
|
—— | N-[2-(2-methylphenyl)ethyl]-2-(1-methyltetrazol-5-yl)sulfanylacetamide | —— | C13H17N5OS |
|
—— | 1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-(1-methyltetrazol-5-yl)sulfanylethanone | —— | C13H14N4O3S |
|
—— | 2-(5-Bromothiophen-2-yl)-5-[(1-methyltetrazol-5-yl)sulfanylmethyl]-1,3,4-oxadiazole | —— | C9H7BrN6OS2 |
|
—— | 3-(oxan-4-yl)-5-[(2S)-2-phenylpropyl]sulfanyl-1,2,4-triazol-4-amine | —— | C16H22N4OS |
|
—— | (2R)-N-propyl-2-[1-(pyridin-2-ylmethyl)imidazol-2-yl]sulfanylpropanamide | —— | C15H20N4OS |
|
—— | 3-(oxan-4-yl)-5-[(2R)-2-phenylpropyl]sulfanyl-1,2,4-triazol-4-amine | —— | C16H22N4OS |
|
—— | (2R)-N-prop-2-enyl-2-[1-(pyridin-2-ylmethyl)imidazol-2-yl]sulfanylpropanamide | —— | C15H18N4OS |
|
—— | (2S)-N-propyl-2-[1-(pyridin-2-ylmethyl)imidazol-2-yl]sulfanylpropanamide | —— | C15H20N4OS |
|
—— | N-[(1R)-1-cyano-1-cyclopropylethyl]-2-[1-(pyridin-2-ylmethyl)imidazol-2-yl]sulfanylacetamide | —— | C17H19N5OS |
|
—— | (2S)-N-cyclopropyl-2-[1-(pyridin-2-ylmethyl)imidazol-2-yl]sulfanylpropanamide | —— | C15H18N4OS |
|
—— | (2S)-N-(2-methylpropyl)-2-[1-(pyridin-2-ylmethyl)imidazol-2-yl]sulfanylpropanamide | —— | C16H22N4OS |
|
—— | (2R)-N-cyclopropyl-2-[1-(pyridin-2-ylmethyl)imidazol-2-yl]sulfanylpropanamide | —— | C15H18N4OS |
|
—— | (2S)-N-prop-2-enyl-2-[1-(pyridin-2-ylmethyl)imidazol-2-yl]sulfanylpropanamide | —— | C15H18N4OS |
|
—— | N-[(1S)-1-cyano-1-cyclopropylethyl]-2-[1-(pyridin-2-ylmethyl)imidazol-2-yl]sulfanylacetamide | —— | C17H19N5OS |
|
—— | [2-[2-(4-bromophenyl)sulfanylethylamino]-2-oxoethyl] (1S,2R)-2-methylcyclopropane-1-carboxylate | —— | C15H18BrNO3S |
|
—— | 2-[(1S)-cyclopent-2-en-1-yl]-N-ethyl-N-[(2S)-1-methylsulfonylpropan-2-yl]acetamide | —— | C13H23NO3S |
|
—— | 2-[(1R)-cyclopent-2-en-1-yl]-N-ethyl-N-[(2S)-1-methylsulfonylpropan-2-yl]acetamide | —— | C13H23NO3S |
|
—— | 2-[(1R)-cyclopent-2-en-1-yl]-N-ethyl-N-[(2R)-1-methylsulfonylpropan-2-yl]acetamide | —— | C13H23NO3S |
|
—— | N-[(2,4-dimethylphenyl)methyl]-2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-methylacetamide | —— | C20H24N4O2S |
|
—— | 2-(3,4-dimethylphenyl)sulfanyl-N-phenylmethoxyacetamide | —— | C17H19NO2S |
|
—— | 3-(4-chlorophenyl)sulfanyl-N-phenylmethoxypropanamide | —— | C16H16ClNO2S |
|
—— | 2-[(4-Benzyl-5-methyl-1,2,4-triazol-3-yl)sulfanyl]-1-[4-(pyridin-4-ylmethyl)piperazin-4-ium-1-yl]ethanone | —— | C22H27N6OS+ |
|
—— | 2-[(4-Benzyl-5-methyl-1,2,4-triazol-3-yl)sulfanyl]-1-[4-(pyridin-4-ylmethyl)piperazin-1-yl]ethanone | —— | C22H26N6OS |
|
—— | 2-[[4-Ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]-1-[4-(pyridin-4-ylmethyl)piperazin-4-ium-1-yl]ethanone | —— | C20H25N6O2S+ |
|
—— | 2-(4-Bromo-2-methylphenyl)sulfanyl-1-[4-(pyridin-4-ylmethyl)piperazin-4-ium-1-yl]ethanone | —— | C19H23BrN3OS+ |
|
—— | (3R)-N-[2-(dimethylamino)pyridin-3-yl]-N-methyl-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C17H19N3OS |
|
—— | (3S)-N-[2-(dimethylamino)pyridin-3-yl]-N-methyl-2,3-dihydro-1-benzothiophene-3-carboxamide | —— | C17H19N3OS |
|
—— | N-[(1S)-1-(2,4-difluorophenyl)ethyl]-3-(4,6-dimethyl-2-methylsulfanylpyrimidin-5-yl)propanamide | —— | C18H21F2N3OS |
|
—— | N-[(1R,2S)-2-ethylsulfanylcyclohexyl]-2-pyridin-4-ylsulfanylacetamide | —— | C15H22N2OS2 |
|
—— | (2R)-N-[(1R)-1-(3-benzyl-1,2,4-oxadiazol-5-yl)ethyl]-2-(2-chlorophenyl)sulfanylpropanamide | —— | C20H20ClN3O2S |
|
—— | N-[(1S,2S)-2-ethylsulfanylcyclohexyl]-2-pyridin-4-ylsulfanylacetamide | —— | C15H22N2OS2 |
|
—— | N-[(1S,2R)-2-ethylsulfanylcyclohexyl]-2-pyridin-4-ylsulfanylacetamide | —— | C15H22N2OS2 |
|